Alkahest, Inc. logo

Alkahest, Inc.

Therapies Born from the Science of Aging

47 employees · est. 2014 · San Carlos, United States

VS
Exosome Diagnostics, a Bio-Techne brand logo

Exosome Diagnostics, a Bio-Techne brand

ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HGPCa and guide biopsy decision.

103 employees · est. 2008 · Waltham, United States

Exosome Diagnostics, a Bio-Techne brand is the older company (2014 vs 2008); Exosome Diagnostics, a Bio-Techne brand is the larger of the two.

Side-by-Side Comparison

Alkahest, Inc. Exosome Diagnostics, a Bio-Techne brand
Founded
2014 2008 older
Headquarters
San Carlos, United States Waltham, United States
Employees
47 103 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care
Funding Stage
Grant Series C
Total Funding
$41.00M $112.08M
Funding Rounds
3 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Exosome-based Diagnostics, Liquid Biopsy, Prostate Cancer, Biopsy Decision, Molecular Diagnostics, Minimally Invasive, Nucleic Acid Profiles, Cancer Detection, Urine Test, Blood Test, Cancer Therapies, Non-invasive Testing, Cancer Biomarkers, Precision Medicine
Website
alkahest.com exosomedx.com
Alkahest, Inc. logo

About Alkahest, Inc.

Alkahest, a subsidiary of Grifols, is developing therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline -- key medical challenges of our generation. The company’s breakthrough research has demonstrated that factors in blood plasma of young mice...

Exosome Diagnostics, a Bio-Techne brand logo

About Exosome Diagnostics, a Bio-Techne brand

Exosome Diagnostics, Inc., founded in 2008 and headquartered in the United States, is making significant strides in the biotechnology and healthcare industries. The company's slogan, "ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HGPCa and guide biopsy decis...

We will tell you when either one moves

BounceWatch watches Alkahest, Inc. and Exosome Diagnostics, a Bio-Techne brand for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Alkahest, Inc. and Exosome Diagnostics, a... — by email.

Frequently Asked Questions

Alkahest, Inc. — Therapies Born from the Science of Aging. Exosome Diagnostics, a Bio-Techne brand — ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HGPCa and guide biopsy decision.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Alkahest, Inc. has raised $41.00M while Exosome Diagnostics, a Bio-Techne brand has raised $112.08M.
Alkahest, Inc. and Exosome Diagnostics, a Bio-Techne brand operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Alkahest, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Alkahest, Inc. on 13 Sep 2024, and Exosome Diagnostics, a Bio-Techne brand on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy